Nanoparticles provoke immune response against tumors but avoid side effects

Cancer drugs that stimulate the body’s immune system to attack tumors are a promising way to treat many types of cancer. However, some of these drugs produce too much systemic inflammation when delivered intravenously, making them harmful to use in patients.

Leave A Comment

Your email address will not be published. Required fields are marked *